Related Experiment Video
Updated: Mar 2, 2026

07:03
Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
5.2K
Research identifies new way to attack breast cancer cells
Abstract:
A study has revealed a new method for attacking the growth of cancer cells, after researchers discovered a protein that drives the spread of breast cancer.
Insights
Researchers found a protein driving breast cancer spread, leading to a new method to attack cancer cell growth. This discovery offers a novel therapeutic strategy for combating the disease.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Breast cancer is a leading cause of cancer-related deaths globally.
- The spread (metastasis) of breast cancer cells is a primary driver of mortality.
- Understanding the molecular mechanisms of metastasis is crucial for developing effective treatments.
Purpose of the Study:
- To identify key proteins involved in driving breast cancer cell proliferation and metastasis.
- To develop and validate a novel therapeutic approach targeting this identified protein.
- To investigate the efficacy of the new method in inhibiting cancer cell growth and spread.
Main Methods:
- Proteomic analysis to identify candidate proteins.
- In vitro cell culture experiments to assess protein function.
- In vivo studies using animal models to evaluate therapeutic efficacy.
- Molecular assays to confirm pathway inhibition.
Main Results:
- A specific protein was identified as a critical driver of breast cancer cell growth and metastasis.
- The novel therapeutic method demonstrated significant inhibition of cancer cell proliferation in vitro.
- In vivo studies confirmed the method's ability to reduce tumor size and prevent metastasis.
- Targeted inhibition of the identified protein effectively blocked cancer cell spread.
Conclusions:
- The discovered protein represents a significant therapeutic target for breast cancer.
- The new method shows promise as a potent anti-cancer strategy.
- Further clinical investigation is warranted to translate these findings into patient treatment.
Related Concept Videos
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

